Cvrx, Inc.
Clinical trials sponsored by Cvrx, Inc., explained in plain language.
-
Nerve-Zapping device could cut heart failure deaths
Disease control ENROLLING_BY_INVITATIONThis study tests a device called Barostim that stimulates nerves to help control heart failure. It involves 2500 adults with moderate heart failure who still have symptoms despite standard medications. The goal is to see if the device reduces deaths and heart-related emergencies …
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
Heart failure device under Real-World watch: 5,000 patients enrolled
Disease control OngoingThis study is a registry that follows 5,000 people with heart failure who have already received a Barostim implant. The goal is to see how safe and helpful the device is in everyday medical practice. Researchers will track symptoms, quality of life, and physical function over tim…
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC